1. Home
  2. IMNM vs WBI Comparison

IMNM vs WBI Comparison

Compare IMNM & WBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • WBI
  • Stock Information
  • Founded
  • IMNM 2006
  • WBI 2016
  • Country
  • IMNM United States
  • WBI United States
  • Employees
  • IMNM N/A
  • WBI N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • WBI Oilfield Services/Equipment
  • Sector
  • IMNM Health Care
  • WBI Energy
  • Exchange
  • IMNM Nasdaq
  • WBI Nasdaq
  • Market Cap
  • IMNM 1.2B
  • WBI 1.1B
  • IPO Year
  • IMNM 2020
  • WBI 2025
  • Fundamental
  • Price
  • IMNM $18.12
  • WBI $23.58
  • Analyst Decision
  • IMNM Strong Buy
  • WBI Buy
  • Analyst Count
  • IMNM 8
  • WBI 8
  • Target Price
  • IMNM $25.75
  • WBI $27.25
  • AVG Volume (30 Days)
  • IMNM 1.4M
  • WBI 474.5K
  • Earning Date
  • IMNM 11-06-2025
  • WBI 11-12-2025
  • Dividend Yield
  • IMNM N/A
  • WBI N/A
  • EPS Growth
  • IMNM N/A
  • WBI N/A
  • EPS
  • IMNM N/A
  • WBI N/A
  • Revenue
  • IMNM $9,679,000.00
  • WBI $645,712,000.00
  • Revenue This Year
  • IMNM N/A
  • WBI $20.74
  • Revenue Next Year
  • IMNM $85.36
  • WBI $11.49
  • P/E Ratio
  • IMNM N/A
  • WBI N/A
  • Revenue Growth
  • IMNM N/A
  • WBI N/A
  • 52 Week Low
  • IMNM $5.15
  • WBI $22.22
  • 52 Week High
  • IMNM $18.79
  • WBI $27.12
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 64.32
  • WBI N/A
  • Support Level
  • IMNM $16.11
  • WBI N/A
  • Resistance Level
  • IMNM $17.94
  • WBI N/A
  • Average True Range (ATR)
  • IMNM 1.26
  • WBI 0.00
  • MACD
  • IMNM 0.02
  • WBI 0.00
  • Stochastic Oscillator
  • IMNM 86.56
  • WBI 0.00

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

About WBI WaterBridge Infrastructure LLC Class A Shares Representing Limited Liability Company Interests

WaterBridge Infrastructure LLC is integrated, pure-play water infrastructure company with operations predominantly in the Delaware Basin, the prolific oil and natural gas basin in North America. It operates the largest produced water infrastructure network in the United States through which it provides water management solutions to oil and natural gas E&P companies under long-term contracts, which include gathering, transporting, recycling and handling produced water. It also operate two energy waste management facilities for the disposal of non-hazardous waste resulting from oil and gas E&P activities, branded under Desert Environmental. The transportation, treatment and handling of produced water is crucial to oil and natural gas production.

Share on Social Networks: